Supernus Pharmaceuticals, Inc. (SUPN) News Headlines

▮ More

Date

Headline

4/2/2021 10:12:18 PM FDA Approves Supernus's Qelbree For Treatment Of Attention-deficit Hyperactivity Disorder

12/23/2020 10:30:58 AM Stock Alert: Supernus Pharmaceuticals Up 14% On Positive Trial Results Of ADHD Drug

12/23/2020 2:32:40 AM CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data

11/10/2020 5:38:39 AM Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN…

11/10/2020 2:35:00 AM ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy

11/8/2020 9:52:03 AM Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing

11/4/2020 10:14:01 AM Stock Alert: Supernus Pharmaceuticals Jumps 22% On Quarterly Results, Sales View

11/4/2020 5:56:13 AM Pre-market Movers In Healthcare Sector: DRAD, SUPN, ARGX, AZN, APVO…

11/1/2020 5:00:11 AM Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation

10/26/2020 1:45:58 AM Biotech Stocks Facing FDA Decision In November 2020

9/14/2020 8:26:50 AM Supernus Submits NDA To FDA For Its Apomorphine Infusion Pump SPN-830

8/19/2020 12:29:27 AM ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY

2/25/2020 10:08:37 PM IOVA Abuzz, SUPN Study Flops, IMV Plunges Despite Positive Ovarian Cancer Data

11/11/2014 5:32:53 PM Supernus Pharmaceuticals, Inc. (SUPN) Has Raised Its FY14 Revenue Estimate To $115 - $118 Mln From $105 Mln

10/22/2012 7:09:33 AM Supernus Pharma Obtains FDA Approval For Oxtellar XR In Epilepsy - Quick Facts

6/26/2012 9:44:14 AM Supernus Pharma's Epilepsy Drug Gets FDA's Tentative Approval; Shares Soar

6/11/2012 5:20:08 AM Supernus Pharma: Inching Closer To FDA Decision

Older Articles